Abstracts tagged "Quality Indicators"

Abstract Number: 2960 • 2018 ACR/ARHP Annual Meeting
Evaluation of Performance Measures Reveals Delays and Sub-Optimal Access to Rheumatology Care and Treatment
Claire Barber¹, Diane Lacaille², Peter Faris³, Dianne P. Mosher⁴, Steven J. Katz⁵, Joanne Homik⁶, Jatin Patel⁷, Sharon Zhang⁷, Cheryl Barnabe⁸, Glen Hazlewood⁹, Vandana Ahluwalia¹⁰, Natalie J. Shiff¹¹, Vivian P. Bykerk¹², Marinka Twilt¹³, Susanne Benseler¹⁴, Jennifer Burt¹⁵ and Deborah A. Marshall¹⁶, ¹Medicine, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada, ²Arthritis Research Canada/University of British Columbia, Medicine/Rheumatology, Richmond, BC, Canada, ³Alberta Health Services, Alberta, AB, Canada, ⁴Med, University of Calgary, Calgary, AB, Canada, ⁵Rheumatology, University of Alberta, Edmonton, AB, Canada, ⁶University of Alberta, Edmonton, AB, Canada, ⁷Alberta Health Services, Calgary, AB, Canada, ⁸Medicine, University of Calgary, Calgary, AB, Canada, ⁹Departments of Medicine and Community Health Sciences, University of Calgary, Calgary, AB, Canada, ¹⁰William Osler Health Center, Brampton, ON, Canada, ¹¹University of Florida, Gainesville, FL, ¹²Deptartment of Rheumatology, Hospital for Special Surgery, New York, NY, ¹³University of Calgary, Calgary, AB, Canada, ¹⁴Pediatric Rheumatology, University of Calgary, Alberta Children's Hospital, Calgary, AB, Canada, ¹⁵St. Clare's Mercy Hospital, Eastern Health, St. John's, NF, Canada, ¹⁶Community Health Sciences, University of Calgary, Calgary, AB, Canada
Background/Purpose: Early diagnosis, treatment and ongoing care are critical to optimize RA outcomes. The purpose of the study was to evaluate key elements of RA…
Abstract Number: 1085 • 2017 ACR/ARHP Annual Meeting
Application of Lupus Nephritis Quality Measures to Understand Gaps in Care for SLE
Lisa Gaynon¹, Maria Dall'Era², Patricia P. Katz², Lindsey A. Criswell², Cristina Lanata², Laura Trupin³, Charles G. Helmick⁴ and Jinoos Yazdany³, ¹Internal Medicine, California Pacific Medical Center, San Francisco, CA, ²Medicine/Rheumatology, University of California, San Francisco, San Francisco, CA, ³Medicine/Rheumatology, University of California San Francisco, San Francisco, CA, ⁴Centers for Disease Control and Prevention, Atlanta, GA
Background/Purpose: In 2012, the ACR released guidelines for monitoring and treatment of lupus nephritis (LN), but studies have yet to evaluate adherence to these recommendations.…
Abstract Number: 1593 • 2017 ACR/ARHP Annual Meeting
Development of Quality Indicator Set of Systemic Lupus Erythematosus in Japan
Nobuyuki Yajima¹, Ken-ei Sada², Shingo Fukuma³, Yasushi Tsujimoto⁴, Sayaka Shimizu³, Kakuya Niihata⁵, Tsuneyo Mimori⁶, Yoshiya Tanaka⁷, Tsutomu Takeuchi⁸, Mayumi Sugiura⁹, Hitoshi Kohsaka¹⁰, Naoto Tamura¹¹, Masataka Kuwana¹², Hideto Kameda¹³, Asano Yoshihide¹⁴, Teruhisa Azuma¹⁵, Toshihiro Matsui¹⁶, Katsuya Suzuki¹⁷, Ryo Takahashi¹, Shunichi Fukuhara³ and Tatsuya Atsumi¹⁸, ¹Div of Rheumatology, Showa University School of Med, Shinagawa-ku Tokyo, Japan, ²Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan, ³Department of Healthcare Epidemiology, Kyoto University Graduate School of Medicine and Public Health, Kyoto, Japan, ⁴Department of Nephrology and Dialysis, Kyoritsu Hospital, Hyogo, Japan, ⁵Division of Clinical Epidemiology, Fukushima Medical University, FUKUSHIMA, Japan, ⁶Department of Rheumatology and Clinical Immunology, Graduate School of Medicine, Kyoto University, Kyoto, Japan, ⁷The First Department of Internal Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan, ⁸Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan, ⁹Department of Obstetrics and Gynecology, Nagoya City University, Graduate School of Medical sciences, Nagoya, Japan, ¹⁰Department of Rheumatology, Tokyo Medical and Dental University (TMDU), Tokyo, Japan, ¹¹Rheumatology, Juntendo University, Tokyo, Japan, ¹²Department of Allergy and Rheumatology, Nippon Medical School Graduate School of Medicine, Tokyo, Japan, ¹³Division of Rheumatology, Department of Internal Medicine, Toho University Ohashi Medical Center, Tokyo, Japan, ¹⁴Dermatology, The University of Tokyo Graduate School of Medicine, Tokyo, Japan, ¹⁵Satellite for Teaching And Research in General Medicine, Fukushima Medical University, Fukushima, Japan, ¹⁶Department of Lifetime Clinical Immunology Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan, ¹⁷Division of Rheumatology, Department of Internal Medicine, Keio University School of Medcine, Tokyo, Japan, ¹⁸Department of Rheumatology, Endocrinology and Nephrology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan
Background/Purpose: A QI set for systemic lupus erythematosus (SLE) was developed in the United States. However, this does not necessarily conform to the Japanese medical…
Abstract Number: 21 • 2017 Pediatric Rheumatology Symposium
Enhancing Quality of Care in Childhood-Onset Systemic Lupus Erythematosus by Improving Performance on Quality Indicator Measures in Cardiovascular and Bone Health
Emily A. Smitherman¹, Adam Furnier², Janalee Taylor³, Mary Beth Burns⁴, Hermine Brunner⁵ and Esi Morgan¹, ¹Pediatric Rheumatology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, ²James M. Anderson Center for Health Systems Excellence, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, ³Division of Rheumatology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, ⁴Cincinnati Children's Hospital Medical Center, Cincinnati, OH, ⁵Rheumatology, PRCSG, Cincinnati, OH
Background/Purpose: Childhood-onset SLE (cSLE) leads to poor health outcomes, including cardiovascular and bone health, due to high rates of potentially devastating disease complications and medication…
Abstract Number: 1404 • 2016 ACR/ARHP Annual Meeting
Systematic Review and Appraisal of Quality Measures for Inflammatory Arthritis
Matthew Cooper¹ and Claire E H Barber², ¹University of Calgary, Calgary, AB, Canada, ²Rheumatology, University of Calgary, Calgary, AB, Canada
Background/Purpose: Quality measures are metrics health professionals can monitor to improve care delivery and patient outcomes. To be measurable they must include a specified numerator,…
Abstract Number: 2247 • 2016 ACR/ARHP Annual Meeting
REAL-Life Cost of UK Healthcare Resource for Patients with Rheumatoid Arthritis, Comparing High and Low/Remission Disease States
Bruce Kirkham¹, Estee Chan², Alexandra Vincent² and Alison Elliott³, ¹Rheumatology, Guy's & St Thomas' NHS Foundation Trust, London, United Kingdom, ²Guy's & St Thomas' NHS Foundation Trust, London, United Kingdom, ³Market Access Directorate, Roche Products LTD UK, Welwyn Garden City, United Kingdom
Background/Purpose: Rheumatoid Arthritis (RA) has differing therapeutic outcomes, with resulting differences in function and quality of life. Little is known about the effects of disease…
Abstract Number: 368 • 2015 ACR/ARHP Annual Meeting
The Effects of Monitoring on a Quality Indicator for Glucocorticoid–Induced Osteoporosis and Trends of the Drug Variation in a Japanese Hospital
Masei Suda¹, Masato Okada¹, Yasuhiro Suyama², Mitsumasa Kishimoto¹ and Tokutaro Tsuda¹, ¹Immuno-Rheumatology Center, St. Luke's International Hospital, Tokyo, Japan, ²Rheumatology, JR Tokyo General Hospital, Tokyo, Japan
Background/Purpose: Glucocorticoid-induced osteoporosis (GIOP) is one of the most clinically significant side effects of glucocorticoid use, and the prevention of GIOP has become more important…
Abstract Number: 999 • 2015 ACR/ARHP Annual Meeting
Development of Quality Indicators for Hip and Knee Arthroplasty Rehabilitation
Marie Westby¹, Deborah Marshall², Jane Squire Howden³ and C. Allyson Jones⁴, ¹School of Public Health, University of Alberta, Edmonton, AB, Canada, ²University of Calgary, Calgary, AB, Canada, ³Edmonton Musculoskeletal Centre, Edmonton, AB, Canada, ⁴Physical Therapy, University of Alberta, Edmonton, AB, Canada
Background/Purpose: Rehabilitation before and after total hip (THA) and knee arthroplasty (TKA) surgery has been shown to decrease pain and impairment, and improve mobility, activity…
Abstract Number: 1998 • 2015 ACR/ARHP Annual Meeting
A National Electronic Health Record-Enabled Registry in Rheumatology: The ACR’s Rheumatology Informatics System for Effectiveness (RISE)
Jinoos Yazdany¹, Rachel Myslinski², Melissa Francisco³, Nick Bansback⁴, Megan E. B. Clowse⁵, Deborah Collier⁶, Karen Law⁷, Katherine Liao⁸, Kaleb Michaud⁹, Esi Morgan-DeWitt¹⁰, Jim Oates¹¹, Catalina Orozco¹², Andreas Reimold¹³, Julia F Simard¹⁴ and Salahuddin Kazi¹⁵, ¹University of California, San Francisco, San Francisco, CA, ²Governance & Ethics Specialist, Amer College of Rheumatology, Atlanta, GA, ³Practice, Advocacy & Quality, American College of Rheumatology, Atlanta, GA, ⁴Population and Public Health, The University of British Columbia, Vancouver, BC, Canada, ⁵Clinical Rheumatologist, Duke University Medical Center, Durham, NC, ⁶Rheumatology, Allergy, and Immunology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, ⁷Emory University School of Medicine, Atlanta, GA, ⁸Division of Rheumatology, Immunology, and Allergy, Brigham & Women's Hospital, Boston, MA, ⁹Rheumatology & Immunology, University of Nebraska Medical Center and National Data Bank, Omaha, NE, ¹⁰Pediatric rheumatology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, ¹¹Medicine, Medical University of South Carolina, Charleston, SC, ¹²Arthritis Consultation Ctr, Dallas, TX, ¹³Rheumatology, VAMC, University of Texas Southwestern Medical Center, Dallas, TX, ¹⁴Division of Epidemiology, Health Research and Policy Department, and Division of Immunology & Rheumatology, Department of Medicine, Stanford School of Medicine, Stanford, CA, ¹⁵Internal Medicine/Rheumatology, UT Southwestern Medical Center, Dallas, TX
Title: A National Electronic Health Record-Enabled Registry in Rheumatology: The ACR's Rheumatology Informatics System for Effectiveness (RISE)Background/Purpose: In 2014, the ACR launched the Rheumatology Informatics…
Abstract Number: 2408 • 2015 ACR/ARHP Annual Meeting
The Quality of Community-Based Osteoarthritis Care Can be Improved. Results from a Systematic Review and Meta-Analysis
Kåre Birger Hagen¹, Geir Smedslund², Nina Østerås² and Gro Jamtvedt³, ¹National Advisory Unit on Rehabilitation in Rheumatology, Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway, ²National Advisory Unit on Rehabilitation in Rheumatology, Department of Rheumatology,, Diakonhjemmet Hospital, Oslo, Norway, ³The Norwegian Knowledge Center for the Health Services, Oslo, Norway
Background/Purpose: The burden of osteoarthritis (OA) is substantial and expected to increase because people are getting older and heavier. Health care providers need to monitor…
Abstract Number: 2507 • 2015 ACR/ARHP Annual Meeting
A Quality Indicator for the Screening of Latent Tuberculosis Infection and the Result of Follow-up Interferon-Gamma-Release Assays in Patients with Rheumatic Disease Receiving Biologic Agents in a Japanese Hospital
Yasuhiro Suyama^1,2, Mitsumasa Kishimoto², Chisun Min³, Yuko Kataoka², Masei Suda², Ryo Rokutanda², Yukio Matsui², Ken-ichi Yamaguchi², Tokutaro Tsuda², Shunya Kaneshita², Hisanori Shimizu² and Masato Okada², ¹Rheumatology, JR Tokyo General Hospital, Tokyo, Japan, ²Immuno-Rheumatology Center, St. Luke's International Hospital, Tokyo, Japan, ³Division of Allergy and Rheumatology, St. Luke's International Hospital, Tokyo, Japan
Background/Purpose: Infection is one of the most devastating side effects of biologic agents use, particularly early on in the course of therapy. Prevention is considered…
Abstract Number: 2508 • 2015 ACR/ARHP Annual Meeting
Adherence to ACR Guidelines in the Management of Lupus Nephritis – a Quality Improvement Initiative
Erik Anderson¹, Matthew Abramson¹, Sanjay Godhwani², Yaqi Xue³, Jie Yang³ and Heidi Roppelt⁴, ¹Internal Medicine, Stony Brook Hospital, Stony Brook, NY, ²Medicine/Rheumatology, Stony Brook Medicine, Setauket, NY, ³Stony Brook University, Stony Brook, NY, ⁴Rheumatology, SUNY Stony Brook Unversity Hospital, East Setauket, NY
Background/Purpose: Lupus nephritis not only decreases survival, but also its costs are substantial, likely due in part to deficits in care (Carls et al.,…
Abstract Number: 2320 • 2014 ACR/ARHP Annual Meeting
Initial Benchmarking of the Quality of Medical Care of Childhood-Onset Systemic Lupus Erythematosus
Ahmad I. Zaal¹, Rina Mina², Simone Appenzeller³, Julia Harris⁴, Marco F. Silva⁵, Jiha Lee⁶, Prachi Khandekar⁷, Maraisa Centeville³, HaiMei Liu², Joshua D. Pendl², Anne Johnson², Jennifer L. Huggins¹, Raju Khubchandani⁸, Stacy P. Ardoin⁹, Marisa S. Klein-Gitelman¹⁰, Clovis A. Silva¹¹ and Hermine I. Brunner¹², ¹Pediatric Rheumatology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, ²Rheumatology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, ³Medicine, Faculty of Medical Science, State University of Campinas Unicamp, São Paulo, Brazil, ⁴Rheumatology, Children's Hospital of Wisconsin, Milwaukee, WI, ⁵Pediatric Rheumatology Unit-Children’s Institute,, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil, ⁶Internal Medicine, University of Cincinnati Medical Center, Cincinnati, OH, ⁷Rhrumatology, Jaslok Hospital and Research Center, Mumbai, India, ⁸Rheumatology, Jaslok Hospital and Research Center, Mumbai, India, ⁹Pediatric & Adult Rheumatology, Ohio State University College of Medicine, Columbus, OH, ¹⁰Division of Rheumatology, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, IL, ¹¹Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil, ¹²Cincinnati Children's Hospital Medical Center, Cincinnati, OH
Background/Purpose: Quality indicators (QI) are minimum standards of medical care in support of optimal disease outcomes. In childhood-onset systemic lupus erythematous (cSLE), 26 QI’s, which…
Abstract Number: 2109 • 2014 ACR/ARHP Annual Meeting
Are Patient Ratings of Providers and Health Plans Associated with Technical Quality of Care in SLE?
Edward H. Yelin¹, Laura Trupin², Jinoos Yazdany² and Chris Tonner³, ¹Arthritis Research Group, University of California, San Francisco, San Francisco, CA, ²Medicine, University of California, San Francisco, San Francisco, CA, ³3333 California Street, Box 09, University of California, San Francisco, San Francisco, CA
Background/Purpose . Prior research has shown that the technical quality of SLE care is associated with the degree of subsequent accumulated damage. However, it is…
Abstract Number: 1833 • 2014 ACR/ARHP Annual Meeting
Quality of Primary Care Management of Patients with and without Rheumatoid Arthritis (RA)
Jessica Widdifield¹, Claire Bombardier², Jacqueline Young¹, Noah Ivers³, R. Liisa Jaakkimainen⁴, Sasha Bernatsky⁵, J. Michael Paterson¹, J. Carter Thorne⁶, Pooneh S.Akhavan⁷, Debra Butt¹, Vandana Ahluwalia⁸ and Karen Tu¹, ¹Institute for Clinical Evaluative Sciences, Toronto, ON, Canada, ²Rheumatology, University of Toronto, Toronto, ON, Canada, ³University of Toronto, Toronto, ON, Canada, ⁴Sunnybrook Health Sciences Centre, Toronto, ON, Canada, ⁵Divisions of Rheumatology and Clinical Epidemiology, McGill University Health Centre, Montreal, QC, Canada, ⁶Southlake Regional Health Centre, Newmarket, Newmarket, ON, Canada, ⁷Mount Sinai Hospital, Toronto, ON, Canada, ⁸William Osler Health Center, Brampton, ON, Canada
Background/Purpose: Little is known about the quality of care received by patients with multiple chronic conditions in primary care and whether quality care is different…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].